Paclitaxel

PACLITAXEL

By APP Pharmaceuticals, LLC | Last revised: 21 January 2011

Paclitaxel Injection USP is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, paclitaxel is indicated in combination with cisplatin. Paclitaxel Injection USP is indicated for…

Paclitaxel

Paclitaxel

By Bedford Laboratories | Last revised: 15 August 2011

Paclitaxel is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, paclitaxel is indicated in combination with cisplatin. Paclitaxel is indicated for the adjuvant treatment of…

Paclitaxel

Paclitaxel

By Sandoz Inc. | Last revised: 20 September 2011

Paclitaxel Injection USP is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy. Paclitaxel Injection USP is indicated in combination with cisplatin. Paclitaxel Injection USP is…

Paclitaxel

Paclitaxel

By Onco Therapies Limited | Last revised: 18 October 2011

Paclitaxel Injection is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first- line therapy, paclitaxel is indicated in combination with cisplatin. Paclitaxel Injection is indicated for the…

Paclitaxel

Paclitaxel

By Pfizer Laboratories Div Pfizer Inc. | Last revised: 7 December 2011

Paclitaxel Injection is indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first- line therapy, paclitaxel is indicated in combination with cisplatin. Paclitaxel Injection is indicated for the…